[Clinical trial of a new oral antidiabetic: glypizide].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001645:Biguanides / Q000008:administration & dosage / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003510:Cyclohexanes / Q000031:analogs & derivatives; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001645:Biguanides; D003510:Cyclohexanes; D007328:Insulin; D011719:Pyrazines; D013453:Sulfonylurea Compounds; D014280:Triglycerides; D002784:Cholesterol
Ensaio clínico dum novo antidiabético oral: glipizida